Shanna Van Zwam

Title: Shanna Van Zwam: Innovator in Immunology

Introduction

Shanna Van Zwam is a notable inventor based in Ghent, Belgium. She has made significant contributions to the field of immunology, particularly in the development of novel therapeutic agents for inflammatory and autoimmune diseases.

Latest Patents

Shanna holds a patent for polypeptides comprising immunoglobulin single variable domains targeting IL-6 and TNF-α. This innovative drug aims to treat subjects suffering from inflammatory and autoimmune diseases, specifically rheumatoid arthritis. The patent details polypeptides that include at least three immunoglobulin single variable domains (ISVDs), with at least one ISVD binding to TNF-α and at least two ISVDs binding to IL-6. Additionally, the disclosure encompasses nucleic acids, vectors, and compositions related to this therapeutic approach.

Career Highlights

Throughout her career, Shanna has worked with prominent companies in the pharmaceutical industry, including Ablynx N.V. and Sanofi. Her work has focused on advancing treatments that target critical pathways in inflammatory responses, showcasing her commitment to improving patient outcomes.

Collaborations

Shanna has collaborated with esteemed colleagues such as Heidi Rommelaere and Christian Asbrand. These partnerships have contributed to her innovative research and development efforts in the field of immunology.

Conclusion

Shanna Van Zwam is a pioneering inventor whose work in immunology has the potential to transform the treatment landscape for autoimmune diseases. Her contributions through patents and collaborations highlight her dedication to advancing medical science.